Literature DB >> 9437026

Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin.

P Dournaud1, H Boudin, A Schonbrunn, G S Tannenbaum, A Beaudet.   

Abstract

Using an antipeptide antibody, we reported previously on the distribution of the somatostatin sst2A receptor subtype in rat brain. Depending on the region, immunolabeled receptors were either confined to neuronal perikarya and dendrites or distributed diffusely in tissue. To investigate the functional significance of these distribution patterns, we examined the regional and cellular relationships between somatostatin axons and sst2A receptors in the rat CNS, using double-labeling immunocytochemistry. Light and confocal microscopy revealed a significant correlation (p < 0.02) between the distribution of somatodendritic sst2A receptor immunoreactivity and that of somatostatin terminal fields, both quantitatively and qualitatively. Furthermore, in regions of somatodendritic labeling, a subpopulation of sst2A-immunoreactive cells was also immunopositive for somatostatin, suggesting that a subset of sst2A receptors consists of autoreceptors. By contrast, in regions displaying diffuse sst2A labeling only moderate to low densities of somatostatin terminals were observed, and no significant relationship was found between terminal density and receptor immunoreactivity. At the electron microscopic level, areas expressing somatodendritic sst2A labeling were found by immunogold cytochemistry to display low proportions of membrane-associated, as compared with intracellular, receptors. Conversely, in regions displaying diffuse sst2A receptor labeling, receptors were predominantly associated with neuronal plasma membranes, a finding consistent with the high density of sst2 binding sites previously visualized in these areas by autoradiography. Double-labeling studies demonstrated that in the former but not in the latter regions, sst2A-immunoreactive somata and dendrites were heavily contacted by somatostatin axon terminals. Taken together, these results suggest that the low incidence of membrane-associated receptors observed in regions of somatodendritic sst2A labeling may be caused by downregulation of cell surface receptors by endogenous somatostatin, possibly through ligand-induced receptor internalization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9437026      PMCID: PMC6792775     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Molecular cloning and functional expression of a brain-specific somatostatin receptor.

Authors:  J F Bruno; Y Xu; J Song; M Berelowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  Somatostatin receptors in the central nervous system.

Authors:  M Schindler; P P Humphrey; P C Emson
Journal:  Prog Neurobiol       Date:  1996-09       Impact factor: 11.685

3.  NMDA-receptor regulation of substance P release from primary afferent nociceptors.

Authors:  H Liu; P W Mantyh; A I Basbaum
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

4.  Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus.

Authors:  A V Schally; W Y Huang; R C Chang; A Arimura; T W Redding; R P Millar; M W Hunkapiller; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

5.  N-terminally extended somatostatin: the primary structure of somatostatin-28.

Authors:  L Pradayrol; H Jörnvall; V Mutt; A Ribet
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

6.  Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation.

Authors:  N Hukovic; R Panetta; U Kumar; Y C Patel
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

7.  Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization.

Authors:  J A Koenig; J M Edwardson; P P Humphrey
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

8.  Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary.

Authors:  R M Señarís; P P Humphrey; P C Emson
Journal:  Eur J Neurosci       Date:  1994-12-01       Impact factor: 3.386

9.  Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.

Authors:  K Raynor; W A Murphy; D H Coy; J E Taylor; J P Moreau; K Yasuda; G I Bell; T Reisine
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

Review 10.  Molecular properties of somatostatin receptors.

Authors:  T Reisine; G I Bell
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

View more
  23 in total

1.  Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation.

Authors:  V Bernard; A I Levey; B Bloch
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.

Authors:  M Schreff; S Schulz; M Händel; G Keilhoff; H Braun; G Pereira; M Klutzny; H Schmidt; G Wolf; V Höllt
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 4.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

5.  The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma.

Authors:  N M Abdel-Hamid; O M Mohafez; M H Nazmy; A Farhan; K Thabet
Journal:  Environ Health Prev Med       Date:  2015-03-01       Impact factor: 3.674

6.  Differential targeting and function of alpha2A and alpha2C adrenergic receptor subtypes in cultured sympathetic neurons.

Authors:  Patricia C Brum; Carl M Hurt; Olga G Shcherbakova; Brian Kobilka; Timothy Angelotti
Journal:  Neuropharmacology       Date:  2006-06-05       Impact factor: 5.250

7.  Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra.

Authors:  H Boudin; D Pélaprat; W Rostène; V M Pickel; A Beaudet
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

Review 8.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

9.  Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.

Authors:  Stefano La Rosa; Silvia Uccella; Linda Dainese; Silvia Marchet; Claudia Placidi; Davide Vigetti; Carlo Capella
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

10.  Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.

Authors:  Sanne E Franck; Federico Gatto; Aart Jan van der Lely; Joseph A M J L Janssen; Alof H G Dallenga; A Paul Nagtegaal; Leo J Hofland; Sebastian J C M M Neggers
Journal:  Neuroendocrinology       Date:  2016-07-25       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.